Meridian bioscience stock.

Jan 30, 2023 · Meridian Bioscience has 5 employees across 11 locations and $333.02 m in annual revenue in FY 2022. ... Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B ...

Meridian bioscience stock. Things To Know About Meridian bioscience stock.

Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter 2022-07-07 - 2 views Form of Indemnification Agreement 2022-07-07 - 1 view Agreement and Plan of Merger, dated as of July 7, 2022, by and among Meridian Bioscience, Inc., SD Biosensor, Inc., Columbus Holding Company, and Madeira Acquisition Corp.* 2022-07 …The latest Meridian Bioscience stock prices, stock quotes, news, and VIVO history to help you invest and trade smarter.Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, …Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13.

Meridian Bioscience Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components. Utilizing a variety of methods, their diagnostic tests provide accuracy, simplicity and speed in the early ...Dec 13, 2022 · Summary. Meridian Biosciences released an update saying it set the closing date for its merger on Jan. 31. The stated reason is that the acquiring parties wanted some extra time to get the financing.

In an all-cash transaction valued at approximately $1.53bn, a consortium led by bio-diagnostic company SD Biosensor, Inc. and investment firm SJL Partners LLC is to acquire global provider of diagnostic testing solutions and life science raw materials Meridian Bioscience, Inc. Under the terms of the definitive merger agreement, Meridian ...

Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...Stock VIVO January 30, 2023 NASDAQ 20 minutes delay $33.97 Open 33.95 ... Meridian Bioscience Inc. | 18,715 followers on LinkedIn.The latest closing stock price for Meridian Bioscience on January 30, 2023 is 33.97. The all-time high Meridian Bioscience closing stock price was 33.97 on January 30, 2023. …Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

100% technical buy signals. 8 new highs and up 15.79% in the last month. 4,910 investors are monitoring the stock on Seeking Alpha. ... Meridian Bioscience, Inc., a life science company ...

CINCINNATI, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that based on preliminary results, it expe...

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] BioSensor, Inc (KOSE:A137310) (SDB) and SJL Partners completed the acquisition of Meridian Bioscience, Inc. (NasdaqGS:VIVO) from Impactive Capital LP, …Feb 1, 2023 · Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms ... 7 juil. 2022 ... ... Meridian Bioscience Inc., a Nas. ... stock price on the day before the consortium's first offer before ...

Meridian Bioscience Inc. (VIVO) Company Bio. Meridian Biosciences is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. The company was founded in 1976 and is ...2 Mei 2022 ... One of Cincinnati's largest public companies names new C-suite member · This Cincinnati company was most popular pick in annual stock contest.Jan 31, 2023 · John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.Meridian Bioscience Corp - Company Profile and News - Bloomberg Markets Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, …Robert Ready VIVO stock SEC Form 4 insiders trading. Robert has made over 13 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently Robert sold 10,000 units of VIVO stock worth $77,000 on 11 March 2015.. The largest trade Robert's ever made was selling 28,250 units of Meridian …Meridian Bioscience, Inc. (NASDAQ:VIVO) issued its earnings results on Friday, November, 12th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.03. The company had revenue of $76.20 million for the quarter, compared to analysts' expectations of $68.40 million.

... Atkore International Group (ATKR), Meridian Bioscience, Inc. (VIVO), and MarineMax, Inc. (HZO) that we think have plenty of upside. Read on for details.

EX-99.1 Exhibit 99.1 For Immediate Release MERIDIAN BIOSCIENCE REPORTS RECORD SETTING FIRST QUARTER FISCAL 2021 OPERATING RESULTS AND RAISES FULL YEAR FISCAL 2021 GUIDANCE CINCINNATI, OHIO February 5, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial …Private Equity-Backed. Primary Industry. Diagnostic Equipment. Other Industries. Biotechnology. Former Stock Listing. VIVO. Primary Office. 3471 River Hills ...EX-99.1 Exhibit 99.1 For Immediate Release MERIDIAN BIOSCIENCE REPORTS RECORD SETTING FIRST QUARTER FISCAL 2021 OPERATING RESULTS AND RAISES FULL YEAR FISCAL 2021 GUIDANCE CINCINNATI, OHIO February 5, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial …Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 ezer dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.Section 1.4 Effect of the Merger.The Merger will have the effects set forth in this Agreement and the relevant provisions of the OGCL. Without limiting the generality of the foregoing and subject thereto, at the Effective Time, all the property, rights, privileges, immunities, powers, franchises and authority of the Company and Merger Sub will vest in the Surviving Company and all debts ...Follow. CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies ...

Meridian Bioscience announced July 7 it's entered into a definitive merger agreement to be acquired by a pair of South Korean-based firms, SD Biosensor and SJL Partners, in a deal valued at $1.53 ...

The opportunity to support authentic relationships is what motivates our teams to create accurate solutions that span the range from discovery to diagnosis. We work hard every day to build genuine connections with all of our customers because even in the complex world of healthcare, the solution is simple. We’re here to help people, and we ...

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Jan 14, 2022 · Phillips owns over 7,500 units of Meridian Bioscience stock worth over $446,210 and over the last 20 years he sold VIVO stock worth over $0. In addition, he makes $148,167 as Independent Chairman of the Board at Meridian Bioscience. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Meridian Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]... Atkore International Group (ATKR), Meridian Bioscience, Inc. (VIVO), and MarineMax, Inc. (HZO) that we think have plenty of upside. Read on for details.Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. Meridian Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] 4, 2018 · Markets Stocks Indices Commodities Cryptocurrencies Currencies ETFs News An icon in the shape of a calendar. Economic Earnings. Search markets. A magnifying glass. It indicates, "Click to ...Meridian Bioscience (NASDAQ:VIVO) is a fully-integrated developer of diagnostic systems through its diagnostics segment, ... That means Meridian is a highly valued stock right now, ...Meridian Bioscience has 5 employees across 11 locations and $333.02 m in ... Meridian Bioscience. Stock Price. $34. 2023-01-30. Market Capitalization. $1.5 B.Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]

Nov 12, 2021 · Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] Diagnostics Solutions. Meridian Bioscience provides best-in-class diagnostic platforms, tests, education, and support to help you deliver answers. Which disease do you need to test for? Meet Revogene ®. Learn more about the innovative Revogene molecular platform.Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]:https://instagram. jngtxanixa biosciences stockstocks under 100 dollarsbuying otc stock Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAs a publicly traded company, ownership of Meridian Bioscience, Inc. is constantly changing as shares are bought and sold on the stock market.Meridian Bioscience, Inc. (VIVO) Mission Statement The mission of Meridian Bioscience, Inc. is to provide diagnostic test kits, reagents, and related products and services that are of the highest quality ... fxi holdingswhy are oil company stocks down today Mr. Anderson VIVO stock SEC Form 4 insiders trading. James has made over 3 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 8,500 units of VIVO stock worth $173,230 on 6 January 2023.. The largest trade he's ever made was buying 10,000 units of Meridian …Follow. CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies ... google stock price target Stock VIVO January 30, 2023 NASDAQ 20 minutes delay $33.97 Open 33.95 ... Meridian Bioscience Inc. | 18,715 followers on LinkedIn.Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announces that effective today it will have completed the purchase of all the outstanding capital stock of the Bioline group of companies consisting of Bioline Ltd (UK), Bioline GmbH (Germany), Bioline (Aust) Pty Ltd (Australia), Bioline Reagents Ltd, and Bioline USA, Inc for $23.3 million in cash on hand.